ArticleInfectious disease reports2025

Early Use of Liraglutide for the Treatment of Acute COVID-19 Infection: An Open-Label Single-Center Phase II Safety Study with Biomarker Profiling.

Eloara V M Ferreira et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.